electroCore Share Price Today: Live Updates & Key Insights

electroCore share price today is $6.13, up -4.65%. The stock opened at $6.07 against the previous close of $6.555, with an intraday high of $6.4 and low of $6.01.

electroCore Share Price Chart

electroCore

us-stock
To Invest in {{usstockname}}
us-stock

electroCore Share Price Performance

$6.13 -0.0465(-4.65%) ECOR at 23 Mar 2026 12:49 PM Medical Devices
Lowest Today 6.01
Highest Today 6.4
Today’s Open 6.07
Prev. Close 6.555
52 Week High 8.64
52 Week Low 4.16
Day’s Range: Low 6.01 High 6.4
52-Week Range: Low 4.16 High 8.64
1 day return -
1 Week return -4.74
1 month return -12.39
3 month return +25.65
6 month return +22.92
1 year return -15.94
3 year return +41.04
5 year return -81.23
10 year return -

electroCore Institutional Holdings

Vanguard Group Inc 3.04

Vanguard Total Stock Mkt Idx Inv 1.76

International Assets Investment Management, LLC 0.96

Geode Capital Management, LLC 0.88

Vanguard Institutional Extnd Mkt Idx Tr 0.77

Renaissance Technologies Corp 0.68

JAFFETILCHIN INVESTMENT PARTNERS, LLC 0.65

Sontag Advisory LLC 0.59

HighTower Advisors, LLC 0.44

Citadel Advisors Llc 0.43

Fidelity Extended Market Index 0.37

State Street Corp 0.33

BlackRock Inc 0.32

Two Sigma Investments LLC 0.24

Susquehanna International Group, LLP 0.24

iShares Micro-Cap ETF 0.17

Blackrock Extended Mkt Fund CF 0.15

Northern Trust Corp 0.14

Fidelity Nasdaq Composite Index 0.14

Extended Equity Market Fund K 0.13

TOBIAS FINANCIAL ADVISORS, INC. 0.13

Fidelity Total Market Index 0.11

Spartan Extended Market Index Pool F 0.10

Fidelity Series Total Market Index 0.10

UBS Group AG 0.10

Northern Trust Extended Eq Market Idx 0.08

NT Ext Equity Mkt Idx Fd - L 0.08

Spartan Total Market Index Pool G 0.06

NT Ext Equity Mkt Idx Fd - NL 0.06

Bfsg, LLC 0.05

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.05

Vanguard Instl Ttl Stck Mkt Idx Tr 0.04

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.03

State St US Extended Mkt Indx NL Cl C 0.03

Rockefeller Capital Management L.P. 0.02

Vanguard U.S. Eq Idx £ Acc 0.02

Morgan Stanley - Brokerage Accounts 0.02

1290 VT Micro Cap K 0.02

Kozak & Associates, Inc. 0.01

Rialto Wealth Management, LLC 0.01

electroCore Market Status

Strong Buy: 3

Buy: 2

Hold: 0

Sell: 0

Strong Sell: 0

electroCore Fundamentals

Market Cap 49.97 M

PB Ratio 41.8833

PE Ratio 0.0

Enterprise Value 47.83 M

Total Assets 18.67 M

Volume 186990

electroCore Company Financials

Annual Revenue FY23:13399000 13.4M, FY22:8592000 8.6M, FY21:5451200 5.5M, FY20:3495800 3.5M, FY19:2390000 2.4M

Annual Profit FY23:11055000 11.1M, FY22:6976000 7.0M, FY21:4066200 4.1M, FY20:1758300 1.8M, FY19:1233000 1.2M

Annual Net worth FY23:-20592000 -20.6M, FY22:-22162000 -22.2M, FY21:-17218100 -17.2M, FY20:-23511100 -23.5M, FY19:-45147000 -45.1M

Quarterly Revenue Q3/2025:8689000 8.7M, Q2/2025:7381000 7.4M, Q1/2025:6719000 6.7M, Q3/2024:6554000 6.6M, Q2/2024:6139000 6.1M

Quarterly Profit Q3/2025:7470000 7.5M, Q2/2025:6442000 6.4M, Q1/2025:5706000 5.7M, Q3/2024:5489000 5.5M, Q2/2024:5301000 5.3M

Quarterly Net worth Q3/2025:-3405000 -3.4M, Q2/2025:-3671000 -3.7M, Q1/2025:-3855000 -3.9M, Q3/2024:-2497000 -2.5M, Q2/2024:-2655000 -2.7M

About electroCore & investment objective

Company Information electroCore, Inc., a bioelectronic medicine and general wellness company, provides non-invasive vagus nerve stimulation ("nVNS") technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an, app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Organisation Medical Devices

Employees 73

Industry Medical Devices

CEO Mr. Daniel S. Goldberger

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

electroCore FAQs

What is the share price of electroCore today?

The current share price of electroCore is $6.13.

Can I buy electroCore shares in India?

Yes, Indian investors can buy electroCore shares by opening an international trading and demat account with Motilal Oswal.

How to buy electroCore shares in India?

You can easily invest in electroCore shares from India by:

Can I buy fractional shares of electroCore?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of electroCore?

electroCore has a market cap of $49.97 M.

In which sector does electroCore belong?

electroCore operates in the Medical Devices sector.

What documents are required to invest in electroCore stocks?

To invest, you typically need:

What is the PE and PB ratio of electroCore?

The PE ratio of electroCore is N/A and the PB ratio is 41.88.